Trajectories of health-related quality of life and symptom burden in patients with advanced cancer towards the end of life: Longitudinal results from the eQuiPe study.
Moyke A J VersluisNatasja J H RaijmakersArnold BaarsMarieke H J van den Beuken-van EverdingenAlexander de GraeffMarieke H J van den Beuken-van EverdingenWouter K de JongJeroen S KlooverEvelien J M KuipCaroline M P W MandigersDirkje W SommeijerYvette M van der LindenLonneke V van de Poll-FransePublished in: Cancer (2023)
Mean overall HRQOL begins to decline 9 months before death, highlighting the need for early identification and (re)assessment of different symptoms as aspects of HRQOL follow different trajectories. Multimorbidity and reported continuity of care may be associated with the trajectory of HRQOL.